ETON - Eton Pharmaceuticals Inc
IEX Last Trade
4.585
-0.015 -0.327%
Share volume: 35,284
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.60
-0.02
-0.33%
Fundamental analysis
22%
Profitability
8%
Dept financing
28%
Liquidity
75%
Performance
22%
Performance
5 Days
1.32%
1 Month
29.94%
3 Months
27.07%
6 Months
2.68%
1 Year
1.55%
2 Year
101.75%
Key data
Stock price
$4.58
DAY RANGE
N/A - $4.66
52 WEEK RANGE
$3.03 - $5.81
52 WEEK CHANGE
$0.01
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: etonpharma.com
Employees: 39
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: etonpharma.com
Employees: 39
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.
Recent news